These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 443487)

  • 1. Dangerously high doses of haloperidol.
    Thornton WE
    Am J Psychiatry; 1979 Jun; 136(6):859-60. PubMed ID: 443487
    [No Abstract]   [Full Text] [Related]  

  • 2. A fatality during haloperidol treatment: mechanism of sudden death.
    Modestin J; Krapf R; Böker W
    Am J Psychiatry; 1981 Dec; 138(12):1616-7. PubMed ID: 7304797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden death in a patient taking haloperidol.
    Ketai R; Matthews J; Mozdzen JJ
    Am J Psychiatry; 1979 Jan; 136(1):112-3. PubMed ID: 758815
    [No Abstract]   [Full Text] [Related]  

  • 4. Haloperidol, hyperthyroidism, and sudden death.
    Weiner MF
    Am J Psychiatry; 1979 May; 136(5):717-8. PubMed ID: 434256
    [No Abstract]   [Full Text] [Related]  

  • 5. Haloperidol and sudden death due to pulmonary edema.
    Mahutte CK; Nakasato SK; Light RW
    Arch Intern Med; 1982 Oct; 142(10):1951-2. PubMed ID: 7125780
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sudden death following a single oral administration of haloperidol].
    Vorel-Havelkova E; Brombacher PJ
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1301; author reply 1302. PubMed ID: 12138682
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with low doses of haloperidol in the treatment of neuroses.
    Preiningerová O; Zapletálek M; Kudrnová K; Svejkovská J
    Act Nerv Super (Praha); 1979 Oct; 21(3):136. PubMed ID: 517076
    [No Abstract]   [Full Text] [Related]  

  • 8. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
    Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y
    J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol (Haldol) and possible association with fatal sickle cell disease (Hgb S-C).
    Stilwell AD
    Am J Forensic Med Pathol; 1984 Sep; 5(3):286-7. PubMed ID: 6496445
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloperidol: the danger of cardiotoxic effects?
    Ketai R; Mozdzen JJ; Matthews J
    Am J Psychiatry; 1981 Sep; 138(9):1259-60. PubMed ID: 7270742
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sudden death following a single oral administration of haloperidol].
    Remijnse PL; Eeckhout AM; van Guldener C
    Ned Tijdschr Geneeskd; 2002 Apr; 146(16):768-71. PubMed ID: 11998355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal-pharyngeal dystonia as a possible cause of asphyxia with haloperidol treatment.
    Flaherty JA; Lahmeyer HW
    Am J Psychiatry; 1978 Nov; 135(11):1414-5. PubMed ID: 707650
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal.
    Greenblatt DJ; Gross PL; Harris J; Shader RI; Ciraulo DA
    J Clin Psychiatry; 1978 Aug; 39(8):673-5. PubMed ID: 681307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden death and neuroleptic medication.
    Turbott J; Cairns FJ
    Am J Psychiatry; 1984 Jul; 141(7):919-20. PubMed ID: 6375401
    [No Abstract]   [Full Text] [Related]  

  • 15. Professional responsibility.
    Fernando TL
    N Z Med J; 1983 Jun; 96(734):492-3. PubMed ID: 6574387
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perspectives of adequate individual doses].
    Maerz JC
    Acta Psiquiatr Psicol Am Lat; 1979 Mar; 25(1):69-73. PubMed ID: 547686
    [No Abstract]   [Full Text] [Related]  

  • 17. [Administration of high dose haloperidol in a patient refractory to treatment with traditional and atypical neuroleptics].
    Stip E; Bruneau MA
    Encephale; 1996; 22(4):298-300. PubMed ID: 9035986
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol: therapeutic window in schizophrenia.
    Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E
    J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
    McEvoy JP; Stiller RL; Farr R
    J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol dosing strategies.
    Schooler NR
    Am J Psychiatry; 1996 Aug; 153(8):1108; author reply 1109. PubMed ID: 8678185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.